Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age

Synthèse documentaire ASEM

Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age ». Extrait officiel (langue source) : Summary of NACI recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years, including summary of evidence, clinical trial and safety data, authorized preparations and schedule. Consultez la publication officielle pour les recommandations détaillées et leur champ d’application.

Cette synthèse facilite le repérage du document. Pour les recommandations cliniques, consultez toujours la version officielle et sa date de mise à jour.